Optimisation of a primary human CAR‐NK cell manufacturing pipeline
A Pfefferle, J Contet, K Wong, C Chen… - Clinical & …, 2024 - Wiley Online Library
Objectives Autologous chimeric antigen receptor (CAR) T‐cell therapy of B‐cell
malignancies achieves long‐term disease remission in a high fraction of patients and has …
malignancies achieves long‐term disease remission in a high fraction of patients and has …
Optimisation of a primary human CAR-NK cell manufacturing pipeline.
A Pfefferle, J Contet, K Wong, C Chen… - Clinical & …, 2024 - europepmc.org
Objectives Autologous chimeric antigen receptor (CAR) T-cell therapy of B-cell malignancies
achieves long-term disease remission in a high fraction of patients and has triggered intense …
achieves long-term disease remission in a high fraction of patients and has triggered intense …
Optimisation of a primary human CAR-NK cell manufacturing pipeline
A Pfefferle, J Contet, K Wong… - Clinical & …, 2024 - pubmed.ncbi.nlm.nih.gov
Objectives Autologous chimeric antigen receptor (CAR) T-cell therapy of B-cell malignancies
achieves long-term disease remission in a high fraction of patients and has triggered intense …
achieves long-term disease remission in a high fraction of patients and has triggered intense …